Work

Chemotherapy-free treatment with acalabrutinib can benefit patients with chronic lymphocytic leukemia/small lymphocytic lymphoma who were never treated before: a plain language summary of the ELEVATE-TN study

Year: 2025
Type: article
Abstract: patients with chronic lymphocytic leukemia/small lymphocytic lymphoma who were never treated before: a plain language summary of the ELEVATE-TN study,
Language: English
Subfield: Genetics
Field: Medicine
Open Access status: hybrid
Funder: AstraZeneca
OpenAlex ID: W4407980292
FWCI:
Cites:
Cited by:
Related to: 10